Literature DB >> 12511591

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells.

Kip A West1, John Brognard, Amy S Clark, Ilona R Linnoila, Xiaowei Yang, Sandra M Swain, Curtis Harris, Steven Belinsky, Phillip A Dennis.   

Abstract

Tobacco-related diseases such as lung cancer cause over 4.2 million deaths annually, with approximately 400,000 deaths per year occurring in the US. Genotoxic effects of tobacco components have been described, but effects on signaling pathways in normal cells have not been described. Here, we show activation of the serine/threonine kinase Akt in nonimmortalized human airway epithelial cells in vitro by two components of cigarette smoke, nicotine and the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Activation of Akt by nicotine or NNK occurred within minutes at concentrations achievable by smokers and depended upon alpha(3)-/alpha(4)-containing or alpha(7)-containing nicotinic acetylcholine receptors, respectively. Activated Akt increased phosphorylation of downstream substrates such as GSK-3, p70(S6K), 4EBP-1, and FKHR. Treatment with nicotine or NNK attenuated apoptosis caused by etoposide, ultraviolet irradiation, or hydrogen peroxide and partially induced a transformed phenotype manifest as loss of contact inhibition and loss of dependence on exogenous growth factors or adherence to ECM. In vivo, active Akt was detected in airway epithelial cells and lung tumors from NNK-treated A/J mice, and in human lung cancers derived from smokers. Redundant Akt activation by nicotine and NNK could contribute to tobacco-related carcinogenesis by regulating two processes critical for tumorigenesis, cell growth and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12511591      PMCID: PMC151834          DOI: 10.1172/JCI16147

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

Review 1.  Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modelling.

Authors:  J E Tønder; P H Olesen
Journal:  Curr Med Chem       Date:  2001-05       Impact factor: 4.530

2.  Phosphorylation of the PTEN tail regulates protein stability and function.

Authors:  F Vazquez; S Ramaswamy; N Nakamura; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

3.  Choline acetyltransferase, acetylcholinesterase, and nicotinic acetylcholine receptors of human gingival and esophageal epithelia.

Authors:  V T Nguyen; L L Hall; G Gallacher; A Ndoye; D L Jolkovsky; R J Webber; R Buchli; S A Grando
Journal:  J Dent Res       Date:  2000-04       Impact factor: 6.116

4.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

5.  Molecular cloning and mapping of the human nicotinic acetylcholine receptor alpha10 (CHRNA10).

Authors:  L R Lustig; H Peng; H Hiel; T Yamamoto; P A Fuchs
Journal:  Genomics       Date:  2001-05-01       Impact factor: 5.736

6.  alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity.

Authors:  T Kihara; S Shimohama; H Sawada; K Honda; T Nakamizo; H Shibasaki; T Kume; A Akaike
Journal:  J Biol Chem       Date:  2001-01-19       Impact factor: 5.157

7.  alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells.

Authors:  A B Elgoyhen; D E Vetter; E Katz; C V Rothlin; S F Heinemann; J Boulter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

8.  Treatment of human cells with N-Nitroso(acetoxymethyl)methylamine: distribution patterns of piperidine-sensitive DNA damage at the nucleotide level of resolution are related to the sequence context.

Authors:  J F Cloutier; R Drouin; A Castonguay
Journal:  Chem Res Toxicol       Date:  1999-09       Impact factor: 3.739

9.  Characterization of the recombinant human neuronal nicotinic acetylcholine receptors alpha3beta2 and alpha4beta2 stably expressed in HEK293 cells.

Authors:  L E Chavez-Noriega; A Gillespie; K A Stauderman; J H Crona; B O Claeps; K J Elliott; R T Reid; T S Rao; G Velicelebi; M M Harpold; E C Johnson; J Corey-Naeve
Journal:  Neuropharmacology       Date:  2000-10       Impact factor: 5.250

10.  Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer.

Authors:  R L Keith; Y E Miller; R M Gemmill; H A Drabkin; E C Dempsey; T C Kennedy; S Prindiville; W A Franklin
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

View more
  210 in total

Review 1.  Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer.

Authors:  John D Minna
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Cotinine conundrum--a step forward but questions remain.

Authors:  Margaret R Spitz; Christopher I Amos; Laura J Bierut; Neil E Caporaso
Journal:  J Natl Cancer Inst       Date:  2012-04-25       Impact factor: 13.506

3.  α7 nicotinic acetylcholine receptor agonist PNU-282987 attenuates early brain injury in a perforation model of subarachnoid hemorrhage in rats.

Authors:  Kamil Duris; Anatol Manaenko; Hidenori Suzuki; William B Rolland; Paul R Krafft; John H Zhang
Journal:  Stroke       Date:  2011-09-29       Impact factor: 7.914

Review 4.  Chromium genotoxicity: A double-edged sword.

Authors:  Kristen P Nickens; Steven R Patierno; Susan Ceryak
Journal:  Chem Biol Interact       Date:  2010-04-27       Impact factor: 5.192

Review 5.  From smoking to lung cancer: the CHRNA5/A3/B4 connection.

Authors:  M R D Improgo; M D Scofield; A R Tapper; P D Gardner
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

6.  New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer.

Authors:  Anna Chikova; Hans-Ulrich Bernard; Igor B Shchepotin; Sergei A Grando
Journal:  Life Sci       Date:  2012-01-17       Impact factor: 5.037

7.  Effects of cigarette smoke on the human oral mucosal transcriptome.

Authors:  Jay O Boyle; Zeynep H Gümüs; Ashutosh Kacker; Vishal L Choksi; Jennifer M Bocker; Xi Kathy Zhou; Rhonda K Yantiss; Duncan B Hughes; Baoheng Du; Benjamin L Judson; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

8.  Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer.

Authors:  Anupam Paliwal; Thomas Vaissière; Annette Krais; Cyrille Cuenin; Marie-Pierre Cros; David Zaridze; Anush Moukeria; Paolo Boffetta; Pierre Hainaut; Paul Brennan; Zdenko Herceg
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

9.  The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells.

Authors:  Juan Arredondo; Alex I Chernyavsky; Sergei A Grando
Journal:  J Cancer Res Clin Oncol       Date:  2006-07-12       Impact factor: 4.553

10.  The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer.

Authors:  Margaret R Spitz; Christopher I Amos; Qiong Dong; Jie Lin; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2008-10-28       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.